For biopharma companies, the past decade was filled with momentous events in the legal realm, from creation of a new way to challenge patents to the emergence of biosimilar litigation and generic price-fixing suits. Below is a look at major milestones of this era.
The most significant development in patent law was the passage of the America Invents Act of 2011. The statute changed...





